Cancer Genetics falls as co to delay filing annual report due to COVID-19

Vyant Bio

07/04/2020 16:04

** Diagnostic co's  CGIX.O  shares fall 10.6% to $3.10
    ** Company to delay filing of its annual report for year
ended Dec. 31, 2019 due to COVID-19 [https://bit.ly/3bW3g95
]
    ** CGIX could also delay future projects from commencing due
to impact on demand for co's services
    ** Stock has lost nearly half its value this year

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))